< Back to News

NEW STUDY SHOWS ADVANTAGES OF ARMEO®POWER THERAPY AFTER STROKE

18th February 2014

Volketswil, Switzerland, February 18, 2014 – Robotic training with the ArmeoPower, an arm exoskeleton by the Swiss medical device company Hocoma, reduces motor impairment faster and more effectively than conventional therapy after stroke. This is the result of a multicenter study by Verena Klamroth-Marganska, Robert Riener and other scientists of the ETH Zurich, that was recently published in “The Lancet Neurology”.